chr1-45329315-TG-T
Variant summary
Our verdict is Uncertain significance. Variant got 5 ACMG points: 5P and 0B. PVS1_ModeratePM2PP5
The NM_001048174.2(MUTYH):c.1556delC(p.Ala519fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000372 in 1,614,088 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. A519A) has been classified as Likely benign.
Frequency
Consequence
NM_001048174.2 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MUTYH | NM_001048174.2 | c.1556delC | p.Ala519fs | frameshift_variant | 16/16 | ENST00000456914.7 | NP_001041639.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MUTYH | ENST00000456914.7 | c.1556delC | p.Ala519fs | frameshift_variant | 16/16 | 1 | NM_001048174.2 | ENSP00000407590.2 | ||
ENSG00000288208 | ENST00000671898.1 | n.*299delC | non_coding_transcript_exon_variant | 21/21 | ENSP00000499896.1 | |||||
ENSG00000288208 | ENST00000671898 | n.*299delC | 3_prime_UTR_variant | 15/15 | ENSP00000499896.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152196Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.00000795 AC: 2AN: 251494Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135920
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461892Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 727246
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152196Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74358
ClinVar
Submissions by phenotype
Familial adenomatous polyposis 2 Pathogenic:1Uncertain:3
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 15, 2023 | This sequence change results in a frameshift in the MUTYH gene (p.Ala547Glufs*24). While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 3 amino acid(s) of the MUTYH protein and extend the protein by 20 additional amino acid residues. This variant is present in population databases (rs587780086, gnomAD 0.004%). This frameshift has been observed in individual(s) with MUTYH-associated polyposis (PMID: 34704405; external communication). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 127843). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
Uncertain significance, criteria provided, single submitter | clinical testing | All of Us Research Program, National Institutes of Health | Aug 15, 2023 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Jul 26, 2023 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | Nov 20, 2015 | - - |
Hereditary cancer-predisposing syndrome Pathogenic:1Uncertain:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 26, 2023 | The c.1640delC variant, located in coding exon 16 of the MUTYH gene, results from a deletion of one nucleotide at nucleotide position 1640, causing a translational frameshift with a predicted alternate stop codon (p.A547Efs*24). Frameshifts are typically deleterious in nature, however, this frameshift occurs at the 3' terminus of MUTYH, is not expected to trigger nonsense-mediated mRNA decay, and results in the elongation of the protein by 20 amino acids. This variant has been detected in a patient diagnosed with 1-10 adenomas before age 61 (Baert-Desurmont S et al. Eur J Hum Genet. 2018 Nov;26(11):1597-1602). This alteration has also been detected in a biallelic state in multiple patients with polyposis (Ambry internal data). Based on the majority of available evidence to date, this variant is likely to be pathogenic. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Mar 27, 2019 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Feb 21, 2014 | This variant is denoted MUTYH c.1640delC at the cDNA level and p.Ala547GlufsX24 (A547EfsX24) at the protein level. The normal sequence, with the base that is deleted in brackets, is AGTG[C]AGCC. The deletion causes a frameshift in codon 547, which changes an Alanine to a Glutamic Acid, resulting in in the loss of a native stop codon, replacing the last 3 amino acids and likely causing the protein to be extended by 20 more amino acids on the new reading frame. MUTYH Ala547GlufsX24 has not, to our knowledge, been published in the literature as pathogenic or benign. This variant has not been observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project. Despite the frameshift nature of this variant, its location at the end of the protein might not cause a deleterious effect on protein structure or function. Therefore, with the data currently available, we consider MUTYH Ala547GlufsX24 to be a variant of uncertain significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at